Radiofrequency volumetric thermal ablation of symptomatic uterine fibroids: The acessa™procedure

Bruce B. Lee, Keith B. Isaacson, Michael Peter Diamond

Research output: Chapter in Book/Report/Conference proceedingChapter

3 Citations (Scopus)

Abstract

Radiofrequency volumetric thermal ablation (RFVTA, the Acessa ™Procedure) is a new, promising laparoscopic, ultrasound-guided fibroid treatment modality that gained FDA clearance in November 2012. It has been studied in multiple clinical trials. Each trial demonstrated clinically and statistically significant bleeding reduction in patients with heavy menstrual bleeding; significant and durable symptom reduction and quality-of-life improvement regardless bulk, pain, or bleeding symptoms, early return to normal and work activities; and low rates of surgical re-intervention in an outpatient procedure. Ninety-eight percent of Acessa patients would recommend the treatment to a friend who had the same health problem. Surgeons in the various RFVTA studies learned the technique and elements of laparoscopic ultrasound and RFVTA before being proctored during initial cases; generally three proctored procedures were necessary before surgeons felt proficient with basic cases. We present a discussion of the development, features of and clinical outcomes following radiofrequency volumetric thermal ablation (RFVTA) of fibroids.

Original languageEnglish (US)
Title of host publicationLeiomyomas
Subtitle of host publicationRisk Factors, Clinical Manifestations and Treatment Options
PublisherNova Science Publishers, Inc.
Pages175-192
Number of pages18
ISBN (Electronic)9781634636032
ISBN (Print)9781634635844
StatePublished - Jan 1 2015

Fingerprint

pain
quality of life
health

Keywords

  • Animal studies
  • Clinical trials
  • Fibroids
  • Laparoscopic ultrasound
  • Leiomyomas
  • Myomas
  • Radiofrequency ablation

ASJC Scopus subject areas

  • Social Sciences(all)

Cite this

Lee, B. B., Isaacson, K. B., & Diamond, M. P. (2015). Radiofrequency volumetric thermal ablation of symptomatic uterine fibroids: The acessa™procedure. In Leiomyomas: Risk Factors, Clinical Manifestations and Treatment Options (pp. 175-192). Nova Science Publishers, Inc..

Radiofrequency volumetric thermal ablation of symptomatic uterine fibroids : The acessa™procedure. / Lee, Bruce B.; Isaacson, Keith B.; Diamond, Michael Peter.

Leiomyomas: Risk Factors, Clinical Manifestations and Treatment Options. Nova Science Publishers, Inc., 2015. p. 175-192.

Research output: Chapter in Book/Report/Conference proceedingChapter

Lee, BB, Isaacson, KB & Diamond, MP 2015, Radiofrequency volumetric thermal ablation of symptomatic uterine fibroids: The acessa™procedure. in Leiomyomas: Risk Factors, Clinical Manifestations and Treatment Options. Nova Science Publishers, Inc., pp. 175-192.
Lee BB, Isaacson KB, Diamond MP. Radiofrequency volumetric thermal ablation of symptomatic uterine fibroids: The acessa™procedure. In Leiomyomas: Risk Factors, Clinical Manifestations and Treatment Options. Nova Science Publishers, Inc. 2015. p. 175-192
Lee, Bruce B. ; Isaacson, Keith B. ; Diamond, Michael Peter. / Radiofrequency volumetric thermal ablation of symptomatic uterine fibroids : The acessa™procedure. Leiomyomas: Risk Factors, Clinical Manifestations and Treatment Options. Nova Science Publishers, Inc., 2015. pp. 175-192
@inbook{70fa723e0081429ea7b4b713c421a283,
title = "Radiofrequency volumetric thermal ablation of symptomatic uterine fibroids: The acessa™procedure",
abstract = "Radiofrequency volumetric thermal ablation (RFVTA, the Acessa ™Procedure) is a new, promising laparoscopic, ultrasound-guided fibroid treatment modality that gained FDA clearance in November 2012. It has been studied in multiple clinical trials. Each trial demonstrated clinically and statistically significant bleeding reduction in patients with heavy menstrual bleeding; significant and durable symptom reduction and quality-of-life improvement regardless bulk, pain, or bleeding symptoms, early return to normal and work activities; and low rates of surgical re-intervention in an outpatient procedure. Ninety-eight percent of Acessa patients would recommend the treatment to a friend who had the same health problem. Surgeons in the various RFVTA studies learned the technique and elements of laparoscopic ultrasound and RFVTA before being proctored during initial cases; generally three proctored procedures were necessary before surgeons felt proficient with basic cases. We present a discussion of the development, features of and clinical outcomes following radiofrequency volumetric thermal ablation (RFVTA) of fibroids.",
keywords = "Animal studies, Clinical trials, Fibroids, Laparoscopic ultrasound, Leiomyomas, Myomas, Radiofrequency ablation",
author = "Lee, {Bruce B.} and Isaacson, {Keith B.} and Diamond, {Michael Peter}",
year = "2015",
month = "1",
day = "1",
language = "English (US)",
isbn = "9781634635844",
pages = "175--192",
booktitle = "Leiomyomas",
publisher = "Nova Science Publishers, Inc.",
address = "United States",

}

TY - CHAP

T1 - Radiofrequency volumetric thermal ablation of symptomatic uterine fibroids

T2 - The acessa™procedure

AU - Lee, Bruce B.

AU - Isaacson, Keith B.

AU - Diamond, Michael Peter

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Radiofrequency volumetric thermal ablation (RFVTA, the Acessa ™Procedure) is a new, promising laparoscopic, ultrasound-guided fibroid treatment modality that gained FDA clearance in November 2012. It has been studied in multiple clinical trials. Each trial demonstrated clinically and statistically significant bleeding reduction in patients with heavy menstrual bleeding; significant and durable symptom reduction and quality-of-life improvement regardless bulk, pain, or bleeding symptoms, early return to normal and work activities; and low rates of surgical re-intervention in an outpatient procedure. Ninety-eight percent of Acessa patients would recommend the treatment to a friend who had the same health problem. Surgeons in the various RFVTA studies learned the technique and elements of laparoscopic ultrasound and RFVTA before being proctored during initial cases; generally three proctored procedures were necessary before surgeons felt proficient with basic cases. We present a discussion of the development, features of and clinical outcomes following radiofrequency volumetric thermal ablation (RFVTA) of fibroids.

AB - Radiofrequency volumetric thermal ablation (RFVTA, the Acessa ™Procedure) is a new, promising laparoscopic, ultrasound-guided fibroid treatment modality that gained FDA clearance in November 2012. It has been studied in multiple clinical trials. Each trial demonstrated clinically and statistically significant bleeding reduction in patients with heavy menstrual bleeding; significant and durable symptom reduction and quality-of-life improvement regardless bulk, pain, or bleeding symptoms, early return to normal and work activities; and low rates of surgical re-intervention in an outpatient procedure. Ninety-eight percent of Acessa patients would recommend the treatment to a friend who had the same health problem. Surgeons in the various RFVTA studies learned the technique and elements of laparoscopic ultrasound and RFVTA before being proctored during initial cases; generally three proctored procedures were necessary before surgeons felt proficient with basic cases. We present a discussion of the development, features of and clinical outcomes following radiofrequency volumetric thermal ablation (RFVTA) of fibroids.

KW - Animal studies

KW - Clinical trials

KW - Fibroids

KW - Laparoscopic ultrasound

KW - Leiomyomas

KW - Myomas

KW - Radiofrequency ablation

UR - http://www.scopus.com/inward/record.url?scp=84955703056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955703056&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:84955703056

SN - 9781634635844

SP - 175

EP - 192

BT - Leiomyomas

PB - Nova Science Publishers, Inc.

ER -